Novum floor 6
Elevator E Hälsovägen 7
Huddinge 141 57
Sweden
46 7 05 62 51 95
https://www.inhalation.se
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 8
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Manoush Masarrat | Chief Executive Officer | N/A | N/A | 1977 |
Dr. Per Gerde | Chief Scientific Officer & Director | N/A | N/A | 1953 |
Mr. Paolo Raffaelli | Chief Commercial Officer | N/A | N/A | 1965 |
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research. The company's products portfolio includes PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Inhalation Sciences Sweden AB (publ) was founded in 2004 and is headquartered in Huddinge, Sweden.
Inhalation Sciences Sweden AB’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.